- 询价
- abinScience
- China
- HY386035
- 2025年12月19日
- ELISA, IHC, WB
- Mouse
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
E. coli - derived recombinant human CD16a/FCGR3A (Gly17-Gln208).
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
0.01M PBS, pH 7.4.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1 year
- 抗原来源：
Mouse
- 目录编号：
HY386035
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Mouse
- 应用范围：
ELISA, IHC, WB
- 浓度：
1mg/ml
- 靶点：
Low affinity immunoglobulin gamma Fc region receptor III-A, IgG Fc receptor III-A, CD16-II, CD16a antigen, Fc-gamma RIII-alpha, Fc-gamma RIII, Fc-gamma RIIIa, FcRIII, FcRIIIa, FcgammaRIIIA, FcR-10, IgG Fc receptor III-2, CD16a, FCGR3A
- 抗体英文名：
Anti-Human CD16a/FCGR3A Monoclonal Antibody (1A578)
- 抗体名：
Anti-Human CD16a/FCGR3A Monoclonal Antibody (1A578)
- 规格：
50ug/100ug
| Product name | Anti-Human CD16a/FCGR3A Monoclonal Antibody (1A578) |
|---|---|
| Catalog No. | HY386035 |
| Host species | Mouse |
| Species reactivity | Human |
| Immunogen | E. coli - derived recombinant human CD16a/FCGR3A (Gly17-Gln208). |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Clonality | Monoclonal |
| Isotype | IgG |
| Applications | ELISA, IHC, WB |
| Target | Low affinity immunoglobulin gamma Fc region receptor III-A, IgG Fc receptor III-A, CD16-II, CD16a antigen, Fc-gamma RIII-alpha, Fc-gamma RIII, Fc-gamma RIIIa, FcRIII, FcRIIIa, FcgammaRIIIA, FcR-10, IgG Fc receptor III-2, CD16a, FCGR3A |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | \ |
| Accession | P08637 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Clone ID | 1A578 |
| Note | For research use only. |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for ab...
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验• FcγR Binding and ADCC Activity of Human IgG Allotypes. PMID: 32435243
• Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). PMID: 16793771
• A Functional Role for Antibodies in Tuberculosis. PMID: 27667685
• Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions. PMID: 27578889
• Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism. PMID: 37804003
• Expansion of Fcγ Receptor IIIa-Positive Macrophages, Ficolin 1-Positive Monocyte-Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis. PMID: 34042322
• The weaker-binding Fc γ receptor IIIa F158 allotype retains sensitivity to N-glycan composition and exhibits a destabilized antibody-binding interface. PMID: 35921896
• Enhancing activity of FcαRI-bispecific antibodies using glycoengineering. PMID: 40156381
• Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival. PMID: 34497614
Human Monoclonal Antibodies: The Residual Challenge of Antibody Immunogenicity
One of the major reasons for seeking human monoclonal antibodies has been to eliminate immunogenicity seen with rodent antibodies. Thus far, there has yet been no approach which absolutely abolishes that risk for cell-binding antibodies
Generation of a Monoclonal Antibody Library Against Human Embryonic Stem Cells
Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the future to treat various human diseases and to model early human embryonic development in vitro. Fulfilling this potential, however, requires extensive
Monoclonal Antibody-Based Strategies in Autoimmunity and Transplantation
of therapeutic monoclonal antibodies in the fields of transplantation and autoimmunity, and discuss the salient features of antibodies presently used in the clinic-notably anti-T-cell and anticytokine antibodies. The discussion will also focus on the unique
技术资料暂无技术资料 索取技术资料
